Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Question on interview

<< Previous

Bullboard Posts

Next >>

Comment by Inthepezon Nov 24, 2022 1:49pm

149 Views

Post# 35125735

RE:RE:RE:RE:RE: Question on interview

Probably another response to dumpster or his other accounts. Don't bother man. He just spreads fud for day flipping. He sucks at it too; which makes the fud entertaining and was the only redeeming aspect prior to most of the board putting the retard on ignore. You know his bag is just as heavy as anyone else here who is long. Besides the day flipping, he wants company to his misery. Ignore the retard(s).

guilelesscat wrote: Because you'd be selling at a massive loss? Ya know... the main reason ppl don't sell investments. I'd rather take my chances at this point.

What a stupid question.

<< Previous

Bullboard Posts

Next >>

How to trade on the stock market: A beginner’s guide